|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Securities held-to-maturity | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating leases right-of-use assets | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income tax asset, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Prepaid and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Demand deposits | ||||||||||||||||||||
| Savings and NOW deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Funds Purchased | ||||||||||||||||||||
| Federal Reserve Bank BTFP Advances | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Subordinated debt, net of issuance costs | ||||||||||||||||||||
| Subordinated debentures, trust preferred securities | ||||||||||||||||||||
| Escrows | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued interest and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Non-voting common stock, $0.01 par value Issued and outstanding: 820,115 on December 31, 2024, and December 31, 2023 | ||||||||||||||||||||
| Voting Common Stock | ||||||||||||||||||||
| Nonvoting Common Stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Unearned Employee Stock Ownership Plan (ESOP) shares | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...